BR0214742A - Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação - Google Patents

Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação

Info

Publication number
BR0214742A
BR0214742A BR0214742-4A BR0214742A BR0214742A BR 0214742 A BR0214742 A BR 0214742A BR 0214742 A BR0214742 A BR 0214742A BR 0214742 A BR0214742 A BR 0214742A
Authority
BR
Brazil
Prior art keywords
preparation
methods
venlafaxine hydrochloride
crystalline polymorph
hydrochloride crystalline
Prior art date
Application number
BR0214742-4A
Other languages
English (en)
Inventor
Kadum Abdul Nabi Ali
Jun Han
Yong Jai Lee
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0214742A publication Critical patent/BR0214742A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"POLIMORFO CRISTALINO DE CLORIDRATO DE VENLAFAXINA E MéTODOS PARA SUA PREPARAçãO". A presente invenção refere-se a uma nova forma polimórfica cristalina anidra de cloridrato de venlafaxina, com alta estabilidade térmica, métodos para sua preparação, e seu uso.
BR0214742-4A 2001-12-05 2002-12-03 Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação BR0214742A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33582201P 2001-12-05 2001-12-05
PCT/US2002/038401 WO2003050075A1 (en) 2001-12-05 2002-12-03 Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
BR0214742A true BR0214742A (pt) 2004-09-14

Family

ID=23313356

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214742-4A BR0214742A (pt) 2001-12-05 2002-12-03 Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação

Country Status (21)

Country Link
US (2) US7030164B2 (pt)
EP (1) EP1451145A1 (pt)
JP (1) JP2005511736A (pt)
KR (1) KR20050044673A (pt)
CN (1) CN1630631A (pt)
AR (1) AR037744A1 (pt)
AU (1) AU2002348266A1 (pt)
BR (1) BR0214742A (pt)
CA (1) CA2467593A1 (pt)
CO (1) CO5580818A2 (pt)
EC (1) ECSP045136A (pt)
HU (1) HUP0402524A2 (pt)
IL (1) IL162255A0 (pt)
MX (1) MXPA04005305A (pt)
NO (1) NO20042681L (pt)
NZ (1) NZ533363A (pt)
PL (1) PL370552A1 (pt)
RU (1) RU2004120285A (pt)
TW (1) TW200301101A (pt)
WO (1) WO2003050075A1 (pt)
ZA (1) ZA200405248B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
JP4180368B2 (ja) * 2000-10-31 2008-11-12 サンド・アクチエンゲゼルシヤフト 塩酸ベンラファキシンの結晶形
MX2007000851A (es) * 2004-07-22 2007-03-26 Wyeth Corp Procedimiento para el tratamiento de trastornos y dolencias del sistema nervioso.
US20060019966A1 (en) * 2004-07-22 2006-01-26 Wyeth Method for treating nervous system disorders and conditions
CA2574310A1 (en) * 2004-07-22 2006-02-02 Wyeth Method for treating nervous system disorders and conditions
US20070021488A1 (en) * 2005-07-21 2007-01-25 Wyeth Method for treating nervous system disorders and conditions
CA2625832A1 (en) * 2005-10-19 2007-04-26 Vinod Kumar Kansal Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
BRPI0807604A2 (pt) * 2007-02-21 2014-07-22 Sepracor Inc Composto, composição farmacêutica, e, métodos para tratar, prevenir ou controlar deprressão, dor, ansiedade, e incontiência
PL2621891T3 (pl) 2010-10-01 2020-11-16 Shan Dong Luye Pharmaceutical Co., Ltd. Polimorfy chloroworodku 4-metylobenzoesanu 4-[2 dimetyloamino-1-(1- hydroksycykloheksylo)etylo]fenylu, sposoby ich przygotowania i stosowania
CN116768882A (zh) 2012-09-18 2023-09-19 奥斯拜客斯制药有限公司 化合物、及其药物组合物及治疗方法
CN114796209A (zh) 2015-03-06 2022-07-29 奥斯拜客斯制药有限公司 氘代丁苯那嗪或包含氘代丁苯那嗪的组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PT1153603E (pt) * 1993-06-28 2007-01-31 Wyeth Corp Novos tratamentos utilizando derivados de fenetilamina
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1334082A4 (en) * 2000-10-19 2006-02-01 Teva Pharma CRYSTALLINE BASIS OF VENLAFAXINE AND NEW POLYMORPHS OF VENLAFAXINE HYDROCHLORIDE AND PREPARATION THEREOF
JP4180368B2 (ja) * 2000-10-31 2008-11-12 サンド・アクチエンゲゼルシヤフト 塩酸ベンラファキシンの結晶形
WO2002046140A1 (en) 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)

Also Published As

Publication number Publication date
AR037744A1 (es) 2004-12-01
ECSP045136A (es) 2004-07-23
RU2004120285A (ru) 2005-04-10
IL162255A0 (en) 2005-11-20
HUP0402524A2 (hu) 2005-03-29
PL370552A1 (en) 2005-05-30
US7030164B2 (en) 2006-04-18
ZA200405248B (en) 2005-10-03
CN1630631A (zh) 2005-06-22
NZ533363A (en) 2005-10-28
EP1451145A1 (en) 2004-09-01
CO5580818A2 (es) 2005-11-30
MXPA04005305A (es) 2004-09-13
AU2002348266A1 (en) 2003-06-23
NO20042681L (no) 2004-06-25
CA2467593A1 (en) 2003-06-19
WO2003050075A1 (en) 2003-06-19
JP2005511736A (ja) 2005-04-28
KR20050044673A (ko) 2005-05-12
TW200301101A (en) 2003-07-01
US20030109585A1 (en) 2003-06-12
US20060074131A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
BRPI0500585A (pt) Processo para a sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
BR0212185A (pt) Compostos e métodos para a preparação de compostos
BR0214742A (pt) Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação
BR0213931A (pt) Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as
CR7080A (es) Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
WO2005107462A3 (en) Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
DK1082293T3 (da) Formoterol-polymorfer
NZ592533A (en) METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR
ATE450497T1 (de) Formoteroltartrat verfahren und polymorph
BRPI0500395A (pt) Processo para a sìntese de (7-metóxi-1-naftil)acetonitrila e sua aplicação na sìntese de agomelatina
BRPI0509382A (pt) processo para a preparação de um sal monocloridrato de composto, monocloridrato cristalino, processo para obter monocloridrato cristalino, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, uso de monocloridrato cristalino, formulação farmacêutica, e, combinação
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
AR041678A1 (es) Formas cristalinas de clorhidrato de donepezil
BRPI0502037A (pt) Processo para a sìntese de (7-metóxi-1-naftil)acetonitrila e sua aplicação na sìntese de agomelatina
BRPI0411973A (pt) forma polimórfica a do ácido 4-[6-acetil-3-[3-(4-acetil-3-hidróxi-2-propilfeniltio)pro póxi]-2-propilfenóxi]butìrico
BR0214696A (pt) Monoidrato de cloridrato de venlafaxina e métodos para a preparação do mesmo
EE200200583A (et) (E)-N-(6,6-dimetüül-2-hepteen-4-ünüül)-N-metüül-1-naftaleenmetaanamiini (terbinafiin) valmistamise meetod
BR0207716A (pt) Composto, formulação farmacêutica, e, método para a inibição de captação de norepinefrina e de serotonina em mamìferos
BR9806875A (pt) Processo para a preparação de um composto.
BRPI0408752A (pt) processo para o preparo de um polimorfo de maleato de rosiglitazona
WO2005069742A3 (en) Crystal form ii of memantine hydrochloride
BR0116721A (pt) Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina
BR0315840A (pt) Fosfolipìdeos de anel substituìdo anti-protozoários
BR0112849A (pt) Processo para a preparação de um composto quiral, e, composto quiral
BR0209843A (pt) Processo para a preparação de cilastatina sódica amorfa

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A. E 8A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.